Rawcliffe Adrian — SEC insider filings

SEC reporting owner CIK 1555851. 35 insider filings on record with FilingPulse; latest filed 2026-10-07.

Transaction summary — filings shown

Covers all 35 filings on record, filed 2020-08-20 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Wave Life Sciences, Inc. (WVE)Director10—3 legs · 70,815 sh · $806,60412
Adaptimmune Therapeutics PLC (ADAP)Chief Executive Officer, Director25—26 legs · 275,466 sh · $469,20310

Insider filings — Rawcliffe Adrian

FiledFormIssuerReported transactionsSource
2026-10-074Wave Life Sciences, Inc. (WVE)Grant/award (A): 10,700 @ $0 · Grant/award (A): 64,000 (derivative) @ $0EDGAR
2026-08-134Wave Life Sciences, Inc. (WVE)Sale (S): 12,700 @ $5.29EDGAR
2025-12-104Wave Life Sciences Ltd. (WVE)Option exercise (M): 42,000 @ $5.97 · Sale (S): 42,000 @ $15 · Option exercise (M): 42,000 (derivative) @ $0EDGAR
2025-11-144Wave Life Sciences Ltd. (WVE)Sale (S): 16,115 @ $6.79EDGAR
2025-08-134Wave Life Sciences Ltd. (WVE)Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0EDGAR
2025-02-204Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 5,143,248 (derivative) @ $0 · Grant/award (A): 3,428,832 (derivative) @ $0EDGAR
2025-01-174Adaptimmune Therapeutics PLC (ADAP)Sale (S): 30,601 @ $0.58EDGAR
2025-01-154Adaptimmune Therapeutics PLC (ADAP)Sale (S): 12,539 @ $0.59 · Sale (S): 17,934 @ $0.59 · Sale (S): 29,096 @ $0.57EDGAR
2024-08-144Wave Life Sciences Ltd. (WVE)Grant/award (A): 16,115 @ $0 · Grant/award (A): 32,230 (derivative) @ $0EDGAR
2024-01-174Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 7,633,296 (derivative) @ $0 · Grant/award (A): 1,696,272 (derivative) @ $0EDGAR
2024-01-174Adaptimmune Therapeutics PLC (ADAP)Sale (S): 9,304 @ $0.79 · Sale (S): 30,080 @ $0.67EDGAR
2024-01-124Adaptimmune Therapeutics PLC (ADAP)Sale (S): 11,945 @ $0.84 · Sale (S): 17,257 @ $0.85EDGAR
2023-09-014Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,403 @ $0.78EDGAR
2023-08-094Wave Life Sciences Ltd. (WVE)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2023-06-274Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,333 @ $0.92EDGAR
2023-01-174Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 4,690,224 (derivative) @ $0 · Grant/award (A): 1,798,272 (derivative) @ $0EDGAR
2023-01-174Adaptimmune Therapeutics PLC (ADAP)Sale (S): 10,057 @ $1.86EDGAR
2023-01-124Adaptimmune Therapeutics PLC (ADAP)Sale (S): 13,042 @ $1.75 · Sale (S): 18,763 @ $1.71EDGAR
2023-01-044Adaptimmune Therapeutics PLC (ADAP)Sale (S): 5,073 @ $1.69EDGAR
2022-09-014Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,536 @ $1.97EDGAR
2022-08-174Wave Life Sciences Ltd. (WVE)Grant/award (A): 21,000 (derivative) @ $0EDGAR
2022-06-274Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,562 @ $1.63EDGAR
2022-01-184Adaptimmune Therapeutics PLC (ADAP)Sale (S): 11,096 @ $3.19EDGAR
2022-01-134Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 4,690,224 (derivative) @ $0 · Grant/award (A): 1,047,480 (derivative) @ $0EDGAR
2022-01-134Adaptimmune Therapeutics PLC (ADAP)Sale (S): 14,362 @ $3.56 · Sale (S): 3,046 @ $3.54EDGAR
2022-01-054Adaptimmune Therapeutics PLC (ADAP)Sale (S): 5,532 @ $4.06EDGAR
2021-09-014Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,782 @ $5.20EDGAR
2021-08-184Wave Life Sciences Ltd. (WVE)Grant/award (A): 42,000 (derivative) @ $0EDGAR
2021-06-284Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,794 @ $4.37EDGAR
2021-01-194Adaptimmune Therapeutics PLC (ADAP)Sale (S): 9,879 @ $5.67EDGAR
2021-01-124Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,707 @ $6.15EDGAR
2021-01-114Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 3,260,400 (derivative) @ $0 · Grant/award (A): 728,160 (derivative) @ $0EDGAR
2021-01-054Adaptimmune Therapeutics PLC (ADAP)Sale (S): 4,967 @ $5.33EDGAR
2020-09-024Adaptimmune Therapeutics PLC (ADAP)Sale (S): 2,776 @ $8.51EDGAR
2020-08-204Wave Life Sciences Ltd. (WVE)Grant/award (A): 10,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1555851 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs